Morphologic classification of hypertrophic cardiomyopathy with myocardial single photon emission tomography. Comparison to echocardiograpnic classification;Clasificación morfológica de la miocardiopatía hipertrófica mediante tomogammagrafía miocárdica. Comparación con la clasificación ecocardiográfica

Revista Espanola de Cardiologia

Volumn 53, Issue 4, 2000, Pages 511-516

  Rornero Farina, Guillermo ^a   Candell Riera, Jaume ^a   Pereztol Valdés, Osvaldo ^a   Galve Basilio, Enrique ^a   Palet Balart, Jordi ^a   Del Castillo, Herminio García ^a   Aguadé Bruix, Santiago ^a   Castell Conesa, Joan ^a   Ortega Alcalde, Domingo ^a   Soler Soler, Jordi ^a  

^a NONE

Author keywords

Echocardiography; Hypertrohic cardiomyopathy; Myocardium; Scintigraphy

Indexed keywords

ARTICLE; CLASSIFICATION; COMPARATIVE STUDY; ECHOGRAPHY; FEMALE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; MIDDLE AGED; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0034168111     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(00)75121-9     Document Type: Article

References (28)

1. Wigle ED, Sasson Z, Henderson MA. Ruddy TD. Fulop J, Rakowski H et al, Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophen review. Prog Cardiovasc Dis 1985; 28: 1-83.
2. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelation of clinical manifestations. pathophysiology and therapy. N Engl J Med 1987; 316: 780-789.
3. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKEnna W, Slidmun CH et. al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med 1992; 326: 1108-1114.
4. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation. 1995; 92: 1680-92.
5. Maron BJ. Hypertrophic cardiomyopathy. Lancet 1997; 350: 127-133.
6. Maron BJ, Moller JH, Seidman CE, Vincent CM, Dietz HC, Moss AJ et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long-QT syndrome, and Marfan Syndrom. Circulation 1998; 98: 1460-1471.
7. Maron BJ, Casey SA, Poliac LC, Gohman TE, Almquist AK, Aeppli DM. Clinical course of hipertrophic cardiomyopathy in a regional United States cohort. JAMA 1999; 281: 650-655.
8. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenelature. Am J Cardiol 1979; 43: 1242-1244.
9. Maron BJ. Hypertrophic cardioniyopathy. CUrr Probl Cardiol 1993; 18: 643-704.
10. Yamaguchi H, Ishimura T, Nishiyama SH, Nagasaki F, Nakanishi Sh, Takatsu FA et al. Hypertrophic cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979; 44: 401-412.
11. Candell-Riera J, Álvarez.-Auñón A. Balda-Caravedo F, Garcfa del Castillo H, Soler Soler J. Clasificacion de la miocardiopatía hipertrófica mediante ecocardiografía bidimensional. Rev Esp Cardiol 1986; 39: 358-363.
12. Santana Boado C, Candell Riera J. Eficacia diagnóstica del SPET frente a la ergometría convencional y a la gammagrafía planar. En: Candell J, Castell J, Aguadé S, editores. Miocardio en riesgo y miocardio viable. Diagnóstico mediante SPET. Barcelona: Doyma S.A., 1998: 79-106.
13. Candell Riera J, Santana Boado C. SPET miocárdico de esfuerzo y con estimulación farmacológica. En: Candell J, Castell J, Aguadé S, editores. Miocardio en riesgo y miocardio viable. Diagnóstico mediante SPET. Barcelona: Doyma S.A., 1998, 107-132.
14. Castell Conesa J, Santana Boado C. Candell Riera J. Aguadé Bruix S, Olona M, Canela T et al. La tomogammagratía miocárdica de esfuerzo en el diagnóstico de la enfermedad coronaria multivaso. Rev Esp Cardiol 1997; 50: 635-642.
15. 99mTc-MIBI. Rev Esp Cardiol 1998; 51: 297-301.
16. Santana Boado C, Candell Riera J, Aguadé Bruix S, Castell Conesa J, Bermejo Fraile B, Canela Coll T et al. Cuantificación de la isquemia miocárdica en regiones dependientes de arterias coronarias ocluidas de pacientes sin infarlo previo. Rev Esp Cardiol 1998; 51: 388-395.
17. Candell Riera J, de la Hera JM, Santana Boado C, Castell Conesa J. Aguadé Bruix S, Bermejo B et al. Eficacia diagnóstica de la tomogammagrafía miocárdica en la detección de reestenosis coronaria postangioplastia. Rev Esp Cardiol 1998; 51: 648-654.
18. Pitcher D, Wainwright R, Maisey M, Curry P, Sowton E. Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy. Br Heart J 1980; 44 650-656.
19. Von Dohlen TW, Prisant LM, Frank MJ. Significance of positive-or negative thallium-201 scintigraphy in hypertrophic cardiomyopathy. Am J Cardiol 1989; 64: 498-503.
20. Yamada M, Elliott PM, Kaski JC, Prasad K, Gane JN, Lowe CM et al. Dipyridamole stress thallium-201 perfusion abnormalities in patients with hypertrophic cardiomyopathy. Relationship to clinical presentation and outcome. Eur Heart J I998; 19: 500-507.
21. Bulkey BH, Rouleau J, Strauss HW, Pitt B. Idiopathic hypertrophic subaortic stenosis: detection by thallium-201 myocardial perfusion imaging. N Engl J Med 1975; 293: 1113-1116.
22. Suzuki Y, Kadota K, Nohara R, Tamaki S, Kambara H, Yoshida A et al. Recognition of regional hypertrophic cardiomyopathy using thallium-201 emission-computed tomography: comparison with two-dimensional echocardiography. Am J Cardiol 1984; 53: 1095-1102.
23. Pons-Lladó G, Carreras F, Borrás X, Palmer J, Llauger J, Bayés de Luna A. Comparison of morphologic assessment of hypertrophic cardiomyopathy by magnetic resonance versus echocardiographic imaging. Am J Cardiol 1997; 79: 1651-1656.
24. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol 1981; 48: 418-428.
25. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437-444.
26. Yuste P, García-Fernández MA, Ecocardiografía, técnica-M y bidimensional en el análisis de las miocardiopatías. Rev Lat Cardiol 1981; 2: 443-455.
27. Maron BJ, Spirito P, Chiarella F, Vecchio C. Unusual distribution of left ventricular hypertrophy in obstructive hypertrophic cardiomyopathy: localized posterobasal free wall thickening in two patients. J Am Coll Cardiol 1985; 5: 1474-1477.
28. Lewis JF, Maron BJ. Hypertrophic cardiomyopahty characterized by marked hypertrophy of the posterior left ventricular free wall: significance and clinical implications. J Am Coll Cardiol 1991; 18: 421-428.